Third Pole Therapeutics Stock

Third Pole Therapeutics is a biotechnology company that is developing and commercializing novel, portable inhaled nitric oxide (iNO) delivery systems for the treatment of pulmonary hypertension and other cardio-pulmonary diseases. The company's proprietary technology, known as the iNOvent™ platform, enables on-demand, targeted delivery of iNO to patients in a variety of settings, including hospitals, clinics, and homes. Third Pole Therapeutics aims to improve patient outcomes and quality of life by providing safe, effective, and accessible iNO therapy.